KALA BIO
KALA | NASDAQ
$0.43
-$0.07 (-14.56%)
At close: Sep 30, 2026, 4:00 PM ET
Split Notice: KALA BIO underwent a 1-for-30
split on Nov 16, 2026. Please be aware that not all data may be fully adjusted for the
split yet.
-14.56%
(1D)Rating
Key Statistics
Market Data
Market Cap $8.3M
1D Range
0.41 0.54
52W Range
0.40 95.50
Valuation (TTM)
PE -0.01
PB 0.92
EV/EBITDA -0.12
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $18.25
Cash Flow
FCF Yield -239.2%
SBC Adj. FCF Yield -263.0%
SBC Impact -9.9%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-97.6%
Dil EPS 3Y | 5Y -39.9% |
-31.2%
FCF 3Y | 5Y 21.8% |
41.6%
Returns
ROA -95.3%
ROE -222.3%
ROIC -232.1%
Financial Health
Net Cash
$7.23M
Current Ratio 6.88
Interest Coverage -19.01
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanopart...
Sector Healthcare
Industry Biotechnology
Employees 6
IPO Date Jul 20, 2017
Website www.kalarx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Hold
Price Target
$18.25
Upside
+4144.19%
Buy (0)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove KALA